Cargando…

GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy

BACKGROUND: Oral cavity cancers (ORC) are the most common cancers, and standard treatment is radical surgery with postoperative radiotherapy. However, locoregional failure remains a major problem, indicating radioresistance an important issue. Our previous work has shown that GP96 contributed to rad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chien-Yu, Lin, Ting-Yang, Wang, Hung-Ming, Huang, Shiang-Fu, Fan, Kang-Hsing, Liao, Chun-Ta, Chen, I-How, Lee, Li-Yu, Li, Yen-Liang, Chen, Yin-Ju, Cheng, Ann-Joy, Chang, Joseph T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214142/ https://www.ncbi.nlm.nih.gov/pubmed/21992474 http://dx.doi.org/10.1186/1748-717X-6-136

Ejemplares similares

The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity
por: Tsan, Din-Li, et al.
Publicado: (2012)

Human Papillomavirus-16 Infection in Advanced Oral Cavity Cancer Patients Is Related to an Increased Risk of Distant Metastases and Poor Survival
por: Lee, Li-Ang, et al.
Publicado: (2012)

GP96: safeguarding Treg
por: Zhang, Yongliang, et al.
Publicado: (2015)

Gp96 Peptide Antagonist gp96-II Confers Therapeutic Effects in Murine Intestinal Inflammation
por: Nold-Petry, Claudia A., et al.
Publicado: (2017)

Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma
por: Huang, Shiang-Fu, et al.
Publicado: (2012)

Outcomes of re-irradiation for oral cavity squamous cell carcinoma
por: Chen, Yen-Chao, et al.
Publicado: (2022)

Postoperative Concomitant Chemoradiotherapy Improved Treatment Outcomes of Patients with Oral Cavity Cancer with Multiple-Node Metastases but No Other Major Risk Factors
por: Fan, Kang-Hsing, et al.
Publicado: (2014)

An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma
por: Liao, Chun-Ta, et al.
Publicado: (2016)

Placenta-derived gp96 as a multivalent prophylactic cancer vaccine
por: Zhao, Bao, et al.
Publicado: (2013)

Human α1-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivo
por: Ochayon, David E., et al.
Publicado: (2013)

Chaperone gp96 mediates ER-α36 cell membrane expression
por: Hou, Junwei, et al.
Publicado: (2015)

Extracellular gp96 is a crucial mediator for driving immune hyperactivation and liver damage
por: Guan, Zeliang, et al.
Publicado: (2020)

Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer––Comparison with pathological risk factors according to the NCCN guidelines
por: Lee, Li‐Yu, et al.
Publicado: (2021)

Human Papillomavirus Infections are Common and Predict Mortality in a Retrospective Cohort Study of Taiwanese Patients With Oral Cavity Cancer
por: Lee, Li-Ang, et al.
Publicado: (2015)

Induction of Foxp3 and activation of Tregs by HSP gp96 for treatment of autoimmune diseases
por: Xu, Yuxiu, et al.
Publicado: (2021)

Regulation of the Expression of Chaperone gp96 in Macrophages and Dendritic Cells
por: Wolfram, Lutz, et al.
Publicado: (2013)

A Nasal Cavity Mucosal Melanoma Connected by Nasolacrimal Duct in a Patient with Multiple Co-morbidities: A Treatment Dilemma
por: Chou, Ching-Feng, et al.
Publicado: (2010)

Plasma gp96 is a Novel Predictive Biomarker for Severe COVID-19
por: Wei, Rongguo, et al.
Publicado: (2021)

Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer
por: Hsieh, Chen-Hsi, et al.
Publicado: (2011)

Identification of gp96 as a Novel Target for Treatment of Autoimmune Disease in Mice
por: Han, Jung Min, et al.
Publicado: (2010)

Pre-Treatment Levels of C-Reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma
por: Chen, Hsuan-Ho, et al.
Publicado: (2013)

Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis
por: Fan, Kang-Hsing, et al.
Publicado: (2017)

gp96 Expression in Gliomas and Its Association with Tumor Malignancy and T Cell Infiltrating Level
por: Li, Chunzhao, et al.
Publicado: (2022)

Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses
por: Zheng, Huaguo, et al.
Publicado: (2019)

The Dual Nature of Specific Immunological Activity of Tumor-derived gp96 Preparations
por: Chandawarkar, Rajiv Y., et al.
Publicado: (1999)

Cell entry of a host-targeting protein of oomycetes requires gp96
por: Trusch, Franziska, et al.
Publicado: (2018)

Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target
por: Duan, Xiaofeng, et al.
Publicado: (2021)

Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with Gastric Cancer
por: Zhang, Kecheng, et al.
Publicado: (2017)

Prognostic impact of extratumoral perineural invasion in patients with oral cavity squamous cell carcinoma
por: Lee, Li‐Yu, et al.
Publicado: (2019)

Interaction of Toll-Like Receptors with the Molecular Chaperone Gp96 Is Essential for Its Activation of Cytotoxic T Lymphocyte Response
por: Liu, Weiwei, et al.
Publicado: (2016)

Induction of Regulatory T Cells by High-Dose gp96 Suppresses Murine Liver Immune Hyperactivation
por: Li, Xinghui, et al.
Publicado: (2013)

Clinical Significance in Oral Cavity Squamous Cell Carcinoma of Pathogenic Somatic Mitochondrial Mutations
por: Lai, Chih-Hsiung, et al.
Publicado: (2013)

Correction: Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses
por: Zheng, Huaguo, et al.
Publicado: (2019)

Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy
por: Wang, Hui-Ching, et al.
Publicado: (2019)

Using SCC Antigen and CRP Levels as Prognostic Biomarkers in Recurrent Oral Cavity Squamous Cell Carcinoma
por: Chen, I-How, et al.
Publicado: (2014)

Gp96 rich lysate as a vaccine candidate against infection with Salmonella typhimurium
por: Hosseini Jazani, N, et al.
Publicado: (2010)

BAAV Transcytosis Requires an Interaction with β-1-4 Linked- Glucosamine and gp96
por: Di Pasquale, Giovanni, et al.
Publicado: (2010)

GP96 Interacts with HHV-6 during Viral Entry and Directs It for Cellular Degradation
por: Prusty, Bhupesh K., et al.
Publicado: (2014)

HCV Core/NS3 Protein Immunization with “N-Terminal Heat Shock gp96 Protein (rNT (gp96))” Induced Strong and Sustained Th1-Type Cytokines in Immunized Mice
por: Hajikhezri, Zamaneh, et al.
Publicado: (2021)

An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result
por: Hung, Tsung-Min, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oubaf3ora9q6pee9mqfsp857ft